4 completed, 4 unknown, 1 recruiting. 9 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 4, Unknown 4, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Howard University: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P) Computerized Chemosensory-Based Orbitofrontal Cortex Training for Pain, Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT) - Chronic Pain, Low Back Pain | Phase 2 | Recruiting | Evon Medics LLC | 220 | 2024-10-23 | 2024-11-04 |
| Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders EDITOR (CBOT with olfactory stimulants, OFC tasks & remote monitoring of treatment compliance), CBOT with olfactory stimulants & OFC tasks, CBOT Sham - Substance Use Disorders, Opioid Use Disorder | Phase 2 | Unknown | Evon Medics LLC | 300 | 2023-07-07 | 2024-05-30 |
| Development and Evaluation of Computerized Olfactory Training Program for Cognitive Decline in Early Alzheimer's Disease COT, Sham - Mild Cognitive Impairment, Early Alzheimer's Disease | Phase 2 | Unknown | Evon Medics LLC | 200 | 2021-11-15 | 2022-05-17 |
| Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use Disorder CBOT + TAU, Sham + TAU - Opioid Use Disorder, Moderate, Opioid Use Disorder, Severe | Phase 2 | Unknown | Evon Medics LLC | 190 | 2021-03-26 | 2021-08-06 |
| Pilot Trial of Transnasal Nicotine in Parkinson Disease Nicotine Nasal Spray 10 MG/ML (0.5 MG/SPRAY) - Parkinson Disease | Phase 2 | Completed | El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez | 6 | 2019-03-04 | 2019-11-06 |
| Effects of Two Doses of MPX Capsules on Rising Prostate-specific Antigen Levels in Men Following Initial Therapy for Prostate Cancer Muscadine Plus Grape Skin Extract, Low-dose MPX, High-dose MPX - Prostate Cancer | Phase 1 / Phase 2 | Completed | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 143 | 2011-07-01 | 2021-04-02 |
| Healthy Outcomes of Pregnancy Education Cognitive Behavioral Therapy - Environmental Tobacco Smoke Exposure, Depression | Phase 2 | Unknown | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1750 | 2001-07-01 | 2006-09-29 |
| Multicenter Trial of Meditation and Health Education for Cardiometabolic Disease in Black Women Health Education, Transcendental Meditation - Atherosclerotic Cardiovascular Disease, Metabolic Syndrome | Phase 2 | Completed | Robert Schneider, MD | 201 | 2001-07-01 | 2025-05-31 |
| Clinical Trial of Meditation for Cardiovascular Disease in Older Black Women Transcendental Meditation, Health Education - Cardiovascular Diseases | Phase 2 | Completed | National Center for Complementary and Integrative Health (NCCIH) | 196 | 1999-10-01 | 2009-12-07 |
Cognitive Dysfunction (2) · Opioid-Related Disorders (2) · Alcoholism (1) · Alzheimer Disease (1) · Atherosclerosis (1) · Cardiovascular Diseases (1) · Chronic Pain (1) · Depression (1) · Health Education (1) · Infant Death (1) · Low Back Pain (1) · Lymphoma, Follicular (1) · Memory Disorders (1) · Metabolic Syndrome (1) · Pain (1)
Meditation (2) · salicylhydroxamic acid (2) · Cognitive Behavioral Therapy (1) · Tobacco Use Cessation Devices (1)
United States (8) · Mexico (1)
Tanya Alim, MD (3) · Charles Nwaokobia (2) · Edwin Chapman, MD (2) · Evaristus Nwulia, MD (2) · Marc Fishman, MD (2) · Evaristus A Nwulia, MD (1) · Evaristus Nwulia, MD, MHS (1) · Haddi Ogunsola, MD (1) · Linda Heaton (1) · Mark Johnson, MD (1) · Michael A Carducci, MD (1) · Michael Serlin, MD (1) · Michele Kiely, DrPH (1) · Robert H. Schneider, MD (1)
PMID 15331239, PMID 17941858, PMID 18835320, PMID 19786427, PMID 20093899, PMID 20211945, PMID 21565525, PMID 21656058, PMID 21785892, PMID 27094910, PMID 28960663, PMID 29863173, PMID 32608505
P50AT000082 (1), R44AG061981 (1), R44DA049616 (1), R44DA056156 (1), R44NS125745 (1), U18HD030445 (1), U18HD030447 (1), U18HD031206 (1), U18HD031919 (1), U18HD036104 (1)